NCT02551068 High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib Status COMPLETED Phase NA
NCT02550873 A Trial to Evaluate the Efficacy of PRM-151 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT02530736 Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase N/A
NCT02503657 Safety, Tolerability, and Efficacy of MN-001 (Tipelukast) in Patients With Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT02502097 A Study of Gefapixant (AF-219/MK-7264) in Participants With Idiopathic Pulmonary Fibrosis (IPF) With Persistent Cough (MK-7264-016) Status COMPLETED Phase PHASE2
NCT02485886 68Ga-BMV101 PET/CT in Patients With Idiopathic Pulmonary Fibrosis Status UNKNOWN Phase EARLY_PHASE1
NCT02478268 Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE1
NCT02477709 A Study to Assess the Tolerability of a Single Dose of Gefapixant (AF-219/MK-7264) in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE2
NCT02460588 Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE3
NCT02445157 Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase N/A
NCT02407431 PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort Status ACTIVE_NOT_RECRUITING Phase N/A
NCT02397005 Study of the Tolerability and Pharmacokinetic of ZL-2102 With an Investigation of Food Effect in Healthy Male Subjects Status UNKNOWN Phase PHASE1
NCT02345070 Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary Fibrosis Status COMPLETED Phase PHASE2
NCT02315586 Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis Status COMPLETED Phase N/A
NCT02268981 Effects of an Oxymizer® During Daytime in Patients With Pulmonary Fibrosis (IPF) Status COMPLETED Phase NA
NCT02267655 3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF Status COMPLETED Phase PHASE1
NCT02257177 RCT (Randomized Control Trial) of TD139 vs Placebo in HV's (Human Volunteers) and IPF Patients Status COMPLETED Phase PHASE1/PHASE2